Pacira Pharma Prices $110M Private Offering of Convertible Notes
January 17, 2013 at 08:07 AM EST
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX ) (the “Company”) today announced that it has priced its private offering of $110 million in aggregate principal amount of its 3.25 percent Convertible Senior Notes due 2019. The Company has also granted the initial purchasers a 30-day option to purchase up to an additional $10 million in
